[ARWR] YoY Quarter Result on 31-Mar-2020 [#Q2]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q2]
Profit Trend
QoQ- -641.81%
YoY- -183.01%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 146,267 151,805 32,811 23,529 48,148 650 8,986 59.16%
PBT 47,676 44,366 -26,818 -19,836 23,897 -14,884 -6,043 -
Tax -999 -2,813 -1,524 0 -0 -150 -81 51.97%
NP 48,675 44,366 -26,818 -19,836 23,897 -14,884 -6,043 -
Tax Rate 2.10% 6.34% - - 0.00% - - -
Total Cost 97,592 107,439 59,629 43,364 24,251 15,534 15,028 36.57%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 33.28 29.23 -81.73 -84.30 49.63 -2,289.45 -67.24 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS 0.46 0.42 -0.26 -0.20 0.25 -0.18 -0.08 -
EPS Diluted 0.45 0.41 -0.26 -0.20 0.24 -0.18 -0.08 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.